Dr Marcus H. Snow: Biosimilar Treatments in Children

Video

Marcus H. Snow, MD, Assistant Professor of Rheumatology, University of Nebraska, discusses the use of biosimilar treatments in children.

Transcript:

Are there special considerations when using biosimilars in children?

Generally, no. Ultimately, in the pediatric realm, we end up having a lot of extrapolation of data and the biosimilars with the pediatric population should not be; ideally, this would be studied as much as it is in the adult world, but we just do not have that as often.

Related Videos
Ha Kung Wong, JD.
Ha Kung Wong, JD
Prerakkumar Parikh, PharmD
Cencora's Corey Ford
Brian Biehn
Chelsee Jensen, PharmD, BCPS
Ryan Haumschild, PharmD, MS, MBA
Stephen Hanauer, MD, professor of medicine, Feinberg School of Medicine, Northwestern University,
Stephen Hanauer, MD, professor of medicine, Feinberg School of Medicine, Northwestern University,
Stephen Hanauer, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.